Day: February 24, 2021

– Preliminary clinical data for menin inhibitor KO-539 highlighted by single-agent activity in relapsed/refractory AML, including patients with NPM1 mutations –– KO-539 continues to demonstrate a wide therapeutic window in dose escalation; protocol amendment to include genetically enriched Phase 1 expansion cohorts –– Tipifarnib receives Breakthrough Therapy Designation from FDA –– $633.3 million in cash, cash equivalents and investments provide runway into 2024 –– Management to host webcast and conference call today at 8:00 a.m. ET –SAN DIEGO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported fourth quarter and full year 2020 financial results and provided a corporate...

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) — Cowen Sustainable Investments (“CSI”), a private sustainability investment strategy within the investment management division of Cowen Inc. (NASDAQ:COWN), today announced it has successfully raised $919 million for its inaugural fund, bringing CSI platform assets to over $1.1 billion. CSI secured commitments from leading institutional investors, sovereign wealth funds and public pension funds, in addition to family offices, and foundations from around the world. The CSI platform leverages its partnership with investors to provide scaled, multi-hundred million dollar capital solutions per investment.CSI was established in 2018 to provide tailored financing and data analytics solutions to companies that are accelerating the world’s transition towards an environmentally sustainable economy....

Sjá meðfylgjandi viðhengi.ViðhengiSíminn hf. – Viðskipti fjárhagslega tengds aðila – Atburður ehf. 240221

An Emerging Markets Sponsored CommentaryORLANDO, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) — Transformative.That’s the key word in a very recent headline for today’s editorial feature regarding diversified health and wellness, beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) which reported that it has closed its previously announced acquisition of Naturo Group Investments Inc. (“Naturo”).You’ll forgive us for not bringing the news of the prospective deal to your digital door but we favor done deals to unfinished works in The EMR.It’s a fascinating acquisition for a cannabis company positioned in a marketplace with renewed affection for the sector and now adding Naturo’s innovative plant-based mineral beverage and supplement brand, TRACE, and significant manufacturing infrastructure and international...

ALPHARETTA, Ga., Feb. 24, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that its fourth quarter and full year 2020 financial results will be reported on Wednesday, March 10, 2021 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.The live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. The live call can be accessed by dialing (844) 263-8310 (domestic) or (213) 358-0959 (international) and entering conference code: 5286349. An archive of the webcast...

NESS ZIONA, Israel, Feb. 24, 2021 (GLOBE NEWSWIRE) — Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will present an overview of the Company and provide a business update at the following virtual investor conferences.Raymond James Institutional Investors ConferenceH.C. Wainwright Global Life Sciences ConferenceA webcast replay of the presentation at H.C. Wainwright Life Sciences Conference will be available in the Investors/Events and Presentations section of the Company’s website at www.sol-gel.com for 30 days.About Sol-Gel TechnologiesSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing...

SPOKANE, Wash., Feb. 24, 2021 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today reported net income attributable to Avista Corp. shareholders of $129.5 million, or $1.90 per diluted share for the year ended Dec. 31, 2020, compared to $197.0 million, or $2.97 per diluted share for the year ended Dec. 31, 2019.For the fourth quarter of 2020, net income attributable to Avista Corp. shareholders was $58.7 million, or $0.85 per diluted share, compared to $50.8 million, or $0.76 per diluted share for the fourth quarter of 2019.“In the midst of this ongoing COVID-19 pandemic, thanks to the dedication and determination of our employees, we’ve taken many steps to move our business forward. We’ve finished installing nearly all of our smart meters across Washington to help our customers better manage their energy usage, and now that the Rattlesnake...

Hermed indkaldes til ordinær generalforsamling i A.P. Møller – Mærsk A/S tirsdag den 23. marts 2021 kl. 10.00. Generalforsamlingen afholdes som fuldstændig elektronisk generalforsamling.Kontaktperson: Executive Vice President, Lars-Erik Brenøe, tlf.: 33 63 36 07Vedhæftede filerIndkaldelseBestyrelsesmedlemmer på valgBilag 1 – Vederlagsrapport

We hereby convene the Annual General Meeting 2021 of A.P. Møller – Mærsk A/S on Tuesday 23 March 2021 at 10.00 a.m. The Annual General Meeting will be held as a completely electronic general meeting. Contact person: Executive Vice President, Lars-Erik Brenøe, tel.: +45 33 63 36 07AttachmentsNotice convening the Annual General MeetingBoard members for electionAppendix 1 – Remuneration Report